Drug Information
Drug General Information | |||||
---|---|---|---|---|---|
Drug ID |
DXO5P3
|
||||
Drug Name |
2-(4-(3-(4-chloro-3-(trifluoromethyl)phenoxy)propoxy)phenylthio)hexanoic acid
|
||||
Synonyms |
CHEMBL551884
|
||||
Indication | Discovery agent | Investigative | [1587926] | ||
Formula |
C22H24ClF3O4S
|
||||
Canonical SMILES |
CCCCC(Sc1ccc(OCCCOc2ccc(Cl)c(c2)C(F)(F)F)cc1)C(=O)O
|
||||
InChI |
InChI=1S/C22H24ClF3O4S/c1-2-3-5-20(21(27)28)31-17-9-6-15(7-10-17)29-12-4-13-30-16-8-11-19(23)18(14-16)22(24,25)26/h6-11,14,20H,2-5,12-13H2,1H3,(H,27,28)
|
||||
InChIKey |
ASHJFOIBKHRPEA-UHFFFAOYSA-N
|
||||
Target and Pathway | |||||
Target(s) | Peroxisome proliferator activated receptor gamma | Target Info | [1587926] | ||
Arachidonate 5-lipoxygenase | Target Info | [1587926] | |||
PANTHER Pathway | CCKR signaling map ST | ||||
PathWhiz Pathway | Arachidonic Acid Metabolism | ||||
WikiPathways | Wnt Signaling Pathway Netpath | ||||
Nuclear Receptors in Lipid Metabolism and Toxicity | |||||
Differentiation of white and brown adipocyte | |||||
Regulation of Lipid Metabolism by Peroxisome proliferator-activated receptor alpha (PPARalpha) | |||||
Transcriptional Regulation of White Adipocyte Differentiation | |||||
Adipogenesis | |||||
SREBP signalling | |||||
Nuclear ReceptorsWP2877:Vitamin D Receptor Pathway | |||||
Arachidonic acid metabolism | |||||
Eicosanoid Synthesis | |||||
Selenium Micronutrient Network | |||||
References |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.